leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 05:31:01 - browse：5685

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Colonoscopy prep: Liquid

hotspot

WSS

Health AI adoption puts security, privacy startups on investors' radar

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Virtual Event: March of the Biosimilars

How Brent Saunders' Allergan experiment failed

Virtual Event: March of the Biosimilars

Wikipedia

leisure time

focus

Jerome Adams on the need for new antivirals for Covid

New chief aims to remake Sanofi Genzyme

State Dept. review finds Biden bears some blame for Afghanistan failures

Why Marc Tessier

Apple is now the first public company to be valued at $3 trillion

What is artificial intelligence? Experts weigh in

23andMe had bad news about my health. I wish a person had delivered it

Methadone treatment changes are coming. Do they go far enough?

As demand for Covid shots wanes, Moderna seeks its next success

A new deal aims to ramp up use of AI in rehab care decisions

leisure time

Gene editing the human germline: What are the risks?

App could help diagnose ear infections more accurately — and at home

Florida babysitter arrested over hot car death, authorities say

Colonoscopy prep: Liquid

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

explore

hotspot

explore

hotspot